Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Center Clinical Trial
Study will advance the validation of Cellvizio as a real-time biopsy guidance tool during robotic-assisted bronchoscopy that may reduce the near-miss rate of peripheral lung cancer Regulatory News: